| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,540,000 |
| Market
Cap: |
346.61(M) |
| Last
Volume: |
34,905,322 |
Avg
Vol: |
12,600,109 |
| 52
Week Range: |
$4.1 - $4.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Mark Robert |
CEO |
• • – |
2012-03-28 |
4 |
AB |
$10.00 |
$3,475 |
D/D |
343 |
40,312 |
|
- |
|
| Scheinberg David A |
Director |
– • – |
2012-02-23 |
4 |
AS |
$10.00 |
$12,500 |
D/D |
(1,250) |
46,185 |
|
- |
|
| Scheinberg David A |
Director |
– • – |
2012-02-23 |
4 |
OE |
$6.90 |
$8,625 |
D/D |
1,250 |
47,435 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-02-22 |
4 |
AB |
$9.40 |
$3,474 |
D/D |
369 |
39,969 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-02-01 |
4 |
AS |
$9.48 |
$9,478 |
D/D |
(1,000) |
38,383 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2012-02-01 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
39,383 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-01-25 |
4 |
AB |
$9.45 |
$3,470 |
D/D |
364 |
39,600 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2012-01-11 |
4 |
AB |
$8.86 |
$3,466 |
D/D |
391 |
39,236 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-12-01 |
4 |
AS |
$6.66 |
$6,660 |
D/D |
(1,000) |
38,383 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-12-01 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
39,383 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2011-11-23 |
4 |
S |
$5.45 |
$3,455 |
D/D |
(634) |
38,313 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2011-10-26 |
4 |
AB |
$6.50 |
$3,467 |
D/D |
532 |
38,211 |
|
- |
|
| Mckinney Robert A |
Senior VP, CFO |
• – – |
2011-10-03 |
4 |
D |
$5.44 |
$13,464 |
D/D |
(2,475) |
44,415 |
|
- |
|
| Mckinney Robert A |
Senior VP, CFO |
• – – |
2011-10-03 |
4 |
OE |
$4.62 |
$12,656 |
D/D |
2,737 |
46,890 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-10-03 |
4 |
D |
$5.44 |
$17,898 |
D/D |
(3,290) |
38,383 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-10-03 |
4 |
OE |
$4.62 |
$16,822 |
D/D |
3,638 |
41,673 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2011-09-28 |
4 |
AB |
$6.38 |
$3,463 |
D/D |
542 |
37,029 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-09-27 |
4 |
AS |
$6.33 |
$4,722 |
D/D |
(746) |
37,843 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-09-27 |
4 |
OE |
$5.33 |
$3,976 |
D/D |
746 |
38,589 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-09-20 |
4 |
AS |
$6.33 |
$633 |
D/D |
(100) |
37,843 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-09-20 |
4 |
OE |
$5.33 |
$533 |
D/D |
100 |
37,943 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-09-01 |
4 |
AS |
$6.33 |
$975 |
D/D |
(154) |
37,843 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-09-01 |
4 |
OE |
$5.33 |
$821 |
D/D |
154 |
37,997 |
|
- |
|
| Baker Mark Robert |
CEO |
• • – |
2011-08-24 |
4 |
AB |
$6.08 |
$3,472 |
D/D |
571 |
36,487 |
|
- |
|
| Israel Robert J |
Senior VP Medical Affairs |
• – – |
2011-08-11 |
4 |
AS |
$6.33 |
$6,330 |
D/D |
(1,000) |
37,843 |
|
- |
|
801 Records found
|
|
Page 4 of 33 |
|
|
